Zimmer Biomet Holdings, Inc. (ZBH) Shares Bought by Andra AP fonden

Andra AP fonden grew its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 7.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,900 shares of the medical equipment provider’s stock after buying an additional 1,600 shares during the period. Andra AP fonden’s holdings in Zimmer Biomet Holdings were worth $2,681,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of ZBH. Ingalls & Snyder LLC raised its holdings in shares of Zimmer Biomet Holdings by 2.6% during the third quarter. Ingalls & Snyder LLC now owns 19,675 shares of the medical equipment provider’s stock worth $2,304,000 after purchasing an additional 507 shares during the last quarter. Caxton Associates LP purchased a new position in shares of Zimmer Biomet Holdings during the first quarter worth $403,000. Koch Industries Inc. raised its holdings in shares of Zimmer Biomet Holdings by 49,697.3% during the second quarter. Koch Industries Inc. now owns 1,040,764 shares of the medical equipment provider’s stock worth $1,033,000 after purchasing an additional 1,038,674 shares during the last quarter. Jensen Investment Management Inc. raised its holdings in shares of Zimmer Biomet Holdings by 24.2% during the second quarter. Jensen Investment Management Inc. now owns 5,850 shares of the medical equipment provider’s stock worth $751,000 after purchasing an additional 1,140 shares during the last quarter. Finally, Commerce Bank raised its holdings in shares of Zimmer Biomet Holdings by 1.5% during the second quarter. Commerce Bank now owns 218,171 shares of the medical equipment provider’s stock worth $28,013,000 after purchasing an additional 3,142 shares during the last quarter. 85.80% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “Zimmer Biomet Holdings, Inc. (ZBH) Shares Bought by Andra AP fonden” was first reported by Transcript Daily and is the property of of Transcript Daily. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The original version of this news story can be accessed at https://transcriptdaily.com/2017/11/11/zimmer-biomet-holdings-inc-zbh-shares-bought-by-andra-ap-fonden.html.

Several research analysts recently issued reports on the stock. Morgan Stanley raised their target price on shares of Zimmer Biomet Holdings from $137.00 to $150.00 and gave the stock an “overweight” rating in a report on Monday, July 17th. Piper Jaffray Companies restated a “buy” rating and set a $141.00 price target on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Stifel Nicolaus restated a “hold” rating and set a $125.00 price target on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Bank of America Corporation restated a “buy” rating and set a $158.00 price target on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Finally, Wells Fargo & Company restated a “market weight” rating on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $134.00.

Zimmer Biomet Holdings, Inc. (NYSE ZBH) opened at $110.75 on Friday. The firm has a market cap of $22,643.58, a PE ratio of 13.86, a P/E/G ratio of 1.74 and a beta of 1.17. Zimmer Biomet Holdings, Inc. has a 52-week low of $95.63 and a 52-week high of $133.49. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.78 and a current ratio of 1.47.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its quarterly earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.02). The business had revenue of $1.82 billion for the quarter, compared to analyst estimates of $1.83 billion. Zimmer Biomet Holdings had a return on equity of 16.29% and a net margin of 8.36%. The business’s revenue was down .8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.79 earnings per share. analysts anticipate that Zimmer Biomet Holdings, Inc. will post 8.04 EPS for the current fiscal year.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply